T. V. Sherstneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
T. V. Sherstneva has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Olga S. Khodorovich
Russian Research Center of Radiology, Ministry of Health of Russia
8 shared publications - Vladimir A. Solodkiy
Russian Scientific Center of Roentgenoradiology
6 shared publications - Alyona A. Kalinina-Masri
Russian Research Center of Radiology, Ministry of Health of Russia
5 shared publications - L. B. Kanakhina
Russian Research Center of Radiology, Ministry of Health of Russia
5 shared publications - V. O. Kleshneva
Russian Research Center of Radiology, Ministry of Health of Russia
4 shared publications - Sh. M. Dibirova
Russian Research Center of Radiology, Ministry of Health of Russia
3 shared publications
Latest Publications
- Open Access
- 20 January 2026
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (4) , 36-44
Use of air-filled breast tissue expander in breast cancer reconstructive surgery
Background. Improved quality of life for patients diagnosed with breast cancer is a consequence of modern advances in oncology surgery and the overall advantage of performing function-sparing surgery. Breast reconstruction has become an important stage of rehabilitation for patients diagnosed with cancer undergoing complex or combined treatment. Aim. To evaluate a new technique for breast reconstruction using prepectoral placement of an air-filled tissue expander. Materials and methods. The article presents data from 155 (34.4 %) of 450 patients who underwent multistep delayed reconstructions, including the stage of installing a tissue expander, which was filled with air. All patients were evaluated before surgery and with different intervals between the stages of reconstruction by photographs in five angles with the patient»s consent. 155 patients underwent immediate breast reconstruction with the installation of a tissue expander prepectorally at the first stage. The cavity of the tissue expander was filled with air. Further, after the strengthening of the covering tissues, the air content was replaced with a saline solution. The average period of restoration of the image and likeness of the mammary gland was 7.6 months (the time from the installation of the tissue expander to its replacement with a permanent silicone endoprosthesis, including the stages of combined / complex treatment, is taken into account). Results. According to the study, no postoperative complications were observed in patients who underwent immediate two-stage breast reconstruction with prepectoral placement of an air-filled tissue expander. All patients received combined / complex treatment for breast cancer within the prescribed timeframe. Conclusion. This technology has been officially patented and is being actively implemented in clinical practice. This technology allows for control of the tissue expander expansion stage with the required pressure on the integumentary tissue and the ability to balance.
- 20 January 2026
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (4) , 36-44
Open AccessUse of air-filled breast tissue expander in breast cancer reconstructive surgery
Background. Improved quality of life for patients diagnosed with breast cancer is a consequence of modern advances in oncology surgery and the overall advantage of performing function-sparing surgery. Breast reconstruction has become an important stage of rehabilitation for patients diagnosed with cancer undergoing complex or combined treatment. Aim. To evaluate a new technique for breast reconstruction using prepectoral placement of an air-filled tissue expander. Materials and methods. The article presents data from 155 (34.4 %) of 450 patients who underwent multistep delayed reconstructions, including the stage of installing a tissue expander, which was filled with air. All patients were evaluated before surgery and with different intervals between the stages of reconstruction by photographs in five angles with the patient»s consent. 155 patients underwent immediate breast reconstruction with the installation of a tissue expander prepectorally at the first stage. The cavity of the tissue expander was filled with air. Further, after the strengthening of the covering tissues, the air content was replaced with a saline solution. The average period of restoration of the image and likeness of the mammary gland was 7.6 months (the time from the installation of the tissue expander to its replacement with a permanent silicone endoprosthesis, including the stages of combined / complex treatment, is taken into account). Results. According to the study, no postoperative complications were observed in patients who underwent immediate two-stage breast reconstruction with prepectoral placement of an air-filled tissue expander. All patients received combined / complex treatment for breast cancer within the prescribed timeframe. Conclusion. This technology has been officially patented and is being actively implemented in clinical practice. This technology allows for control of the tissue expander expansion stage with the required pressure on the integumentary tissue and the ability to balance.
- Open Access
- 3 December 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (4) , 88-94
Epidermal cyst of the mammary gland: a common benign formation of atypical localization
Epidermal cysts can be located anywhere: on the scalp, face, trunk, neck and limbs. In the article, specialists from the Department of Surgical Treatment Methods and Antitumor Drug Therapy for Breast Tumors at the Mammology Clinic of the Russian Research Center of Radiology present a rare clinical case of a cyst of atypical localization and a literature review aimed at raising awareness of the existence of epidermal cysts in the parenchyma of the mammary gland. This clinical experience is also interesting from the point of view of differential diagnostics between other benign and malignant formations of the mammary gland to choose the right treatment tactics.
- 3 December 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (4) , 88-94
Open AccessEpidermal cyst of the mammary gland: a common benign formation of atypical localization
Epidermal cysts can be located anywhere: on the scalp, face, trunk, neck and limbs. In the article, specialists from the Department of Surgical Treatment Methods and Antitumor Drug Therapy for Breast Tumors at the Mammology Clinic of the Russian Research Center of Radiology present a rare clinical case of a cyst of atypical localization and a literature review aimed at raising awareness of the existence of epidermal cysts in the parenchyma of the mammary gland. This clinical experience is also interesting from the point of view of differential diagnostics between other benign and malignant formations of the mammary gland to choose the right treatment tactics.
- Open Access
- 8 November 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (3) , 22-30
Imaging the main molecular biological subtypes of breast cancer: comparison of mammographic data and histological findings
Background. Breast cancer (BC) stands as one of the most prevalent malignancies affecting women, posing a significant threat to health and life. Timely diagnosis and treatment of BC play a pivotal role in enhancing patient survival rates.Aim. To explore such a method of visualization of BC as mammography and the correlation of its results with the data of histological and immunohistochemical studies, and their significance in planning organ-conserving operations.Materials and methods. The study involved 217 patients diagnosed with nodular BC (T1-2N1M0). AH patients underwent digital mammography, histological examination of biopsy and surgical specimens, and immunohistochemical analysis of tumor tissue (determination of the expression of sex hormone receptors (estrogen and progesterone), HER2/neu status and the status of the Ki-67 marker, reflecting the proliferative activity of tumor cells).Results. Comparison of mammographic and histological/immunohistochemical findings revealed significant differences in tumor visualization among major molecular subtypes of BC. A statistically significant association (p 0.001) was established between carcinoma in situ and radiological features such as spiculated margins and calcifications on mammography.Conclusion. Mammography emerges as an objective and accessible visualization method for BC, enabling assessment of tumor size and peritumoral region. However, for planning breast-conserving surgery for luminal and HER2-positive BC subtypes, a multimodal diagnostic approach is recommended to assess tumor spread, incorporating ultrasound and contrast-enhanced magnetic resonance imaging.
- 8 November 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (3) , 22-30
Open AccessImaging the main molecular biological subtypes of breast cancer: comparison of mammographic data and histological findings
Background. Breast cancer (BC) stands as one of the most prevalent malignancies affecting women, posing a significant threat to health and life. Timely diagnosis and treatment of BC play a pivotal role in enhancing patient survival rates.Aim. To explore such a method of visualization of BC as mammography and the correlation of its results with the data of histological and immunohistochemical studies, and their significance in planning organ-conserving operations.Materials and methods. The study involved 217 patients diagnosed with nodular BC (T1-2N1M0). AH patients underwent digital mammography, histological examination of biopsy and surgical specimens, and immunohistochemical analysis of tumor tissue (determination of the expression of sex hormone receptors (estrogen and progesterone), HER2/neu status and the status of the Ki-67 marker, reflecting the proliferative activity of tumor cells).Results. Comparison of mammographic and histological/immunohistochemical findings revealed significant differences in tumor visualization among major molecular subtypes of BC. A statistically significant association (p 0.001) was established between carcinoma in situ and radiological features such as spiculated margins and calcifications on mammography.Conclusion. Mammography emerges as an objective and accessible visualization method for BC, enabling assessment of tumor size and peritumoral region. However, for planning breast-conserving surgery for luminal and HER2-positive BC subtypes, a multimodal diagnostic approach is recommended to assess tumor spread, incorporating ultrasound and contrast-enhanced magnetic resonance imaging.
- Open Access
- 20 December 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (4) , 75-82
Breast calcifications. Literature review
Breast cancer continues to maintain a leading position in the structure of the incidence of all oncological diseases among women. Early diagnosis of the disease at the stage of assessing indirect signs makes it possible in the future to maintain a good quality of life for patients by forming proper dynamic monitoring and performing functionally sparing surgical treatment. Interest in the early detection of benign and malignant pathology of the mammary gland is growing every year. A multidisciplinary approach to the study of the formation of breast calcifications makes it possible to look at the problem in a multifaceted way, and ways to solve problems in the process of diagnosis underlie the biochemical understanding of the mechanisms of formation, which is no less important when evaluating mammographic images. Practically up to 50 % of non-palpable breast tumors in practice are detected by signs of existing calcifications in the gland tissue. At present, the problem of early detection of malignant tumors of the breast by radiographic signs of these calcifications, their shape and nature of location in the gland tissue and their further pathomorphological confirmation is being actively studied.We have analyzed the literature data of foreign and domestic authors over the past 20 years. The problem was considered from the mechanism of formation and morphological features of calcifications in the breast tissue to their radiographic assessment on mammographic images. According to the results of the studied literature, the biochemical features of the formations were taken as the basis for understanding the nature of calcifications in the breast tissue. On a biochemical level, calcifications are usually classified into two main types: type I, consisting of calcium oxalate, and type II, consisting of hydroxyapatite. The classification is based on chemical composition and mammographic characteristics, including morphology, distribution and density. Speaking about calcium oxalate, the benign nature of education is most often implied, which cannot be said about hydroxyapatite. Mammography is the main method for diagnosing these formations, taking into account the characteristics of the characteristic radiological signs, which are also detailed in this article.Understanding the molecular and structural development of calcifications may aid in the detection and treatment of breast lesions. Identification of these structures in a patient diagnosed with breast cancer refers to the early diagnosis of the disease, where, with timely prescribed therapy, we get high chances of good long-term results of relapse-free survival.
- 20 December 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (4) , 75-82
Open AccessBreast calcifications. Literature review
Breast cancer continues to maintain a leading position in the structure of the incidence of all oncological diseases among women. Early diagnosis of the disease at the stage of assessing indirect signs makes it possible in the future to maintain a good quality of life for patients by forming proper dynamic monitoring and performing functionally sparing surgical treatment. Interest in the early detection of benign and malignant pathology of the mammary gland is growing every year. A multidisciplinary approach to the study of the formation of breast calcifications makes it possible to look at the problem in a multifaceted way, and ways to solve problems in the process of diagnosis underlie the biochemical understanding of the mechanisms of formation, which is no less important when evaluating mammographic images. Practically up to 50 % of non-palpable breast tumors in practice are detected by signs of existing calcifications in the gland tissue. At present, the problem of early detection of malignant tumors of the breast by radiographic signs of these calcifications, their shape and nature of location in the gland tissue and their further pathomorphological confirmation is being actively studied.We have analyzed the literature data of foreign and domestic authors over the past 20 years. The problem was considered from the mechanism of formation and morphological features of calcifications in the breast tissue to their radiographic assessment on mammographic images. According to the results of the studied literature, the biochemical features of the formations were taken as the basis for understanding the nature of calcifications in the breast tissue. On a biochemical level, calcifications are usually classified into two main types: type I, consisting of calcium oxalate, and type II, consisting of hydroxyapatite. The classification is based on chemical composition and mammographic characteristics, including morphology, distribution and density. Speaking about calcium oxalate, the benign nature of education is most often implied, which cannot be said about hydroxyapatite. Mammography is the main method for diagnosing these formations, taking into account the characteristics of the characteristic radiological signs, which are also detailed in this article.Understanding the molecular and structural development of calcifications may aid in the detection and treatment of breast lesions. Identification of these structures in a patient diagnosed with breast cancer refers to the early diagnosis of the disease, where, with timely prescribed therapy, we get high chances of good long-term results of relapse-free survival.
- Open Access
- 20 December 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (4) , 54-62
Specific characteristics and challenges associated with breast cancer diagnostics in women after breast augmentation and reconstructive surgeries with implants
Background. The number of plastic surgeries is constantly growing worldwide. Breast augmentation remains the most common surgical procedure in women, which demonstrated a 0.5 % increase over the past 4 years. As the number of women with breast implants increases, specialists and patients themselves face difficulties related to screening, diagnosis, and treatment of tumors, including breast cancer.Aim. To analyze specific characteristics of breast examination in patients after breast augmentation who were examined and treated in the mammological clinic of Russian Research Center of Radiology, Ministry of Health of the Russian Federation.Materials and methods. This study included 273 patients aged between 21 and 63 years (mean age 49.0 ± 7.6 years) after breast augmentation and after reconstructive surgery for breast cancer and symmetrizing surgery on the contralateral side. All women underwent clinical examination plus breast ultrasound (for patients under 40 years of age) or mammography followed by ultrasound (patients over 40 years of age). Patients who were found to have BI-RADS 3–4 tumors underwent ultrasound-guided or stereotactic breast biopsy. In case of suspicious intraductal formations according to breast nipple smears the patients were referred to breast ductography. Patients with suspected implant rupture or capsular contracture, as well as patients requiring the assessment of the disease stage underwent contrast-enhanced magnetic resonance imaging.Results. After comprehensive examination, 12 patients (5.4 %) were diagnosed with breast cancer; 38 patients (13.9 %), with implant rupture; 3 patients (1 %), with intraductal formations.Conclusion. Breast augmentation is not a contraindication to mammography in women aged over 40 years with glandular tissue. Additional examination methods include breast ultrasound, contrast-enhanced mammography, and breast magnetic resonance imaging. In case of no glandular tissue, contrast-enhanced breast magnetic resonance imaging and breast ultrasound are the methods of choice. It is important to develop new standards of screening and diagnosis of breast diseases in women after aesthetic surgery, since breast cancer incidence is likely to increase among women after breast augmentation over the next decades, considering the fact that breast cancer is the most common malignancy in women and its incidence is constantly growing.
- 20 December 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (4) , 54-62
Open AccessSpecific characteristics and challenges associated with breast cancer diagnostics in women after breast augmentation and reconstructive surgeries with implants
Background. The number of plastic surgeries is constantly growing worldwide. Breast augmentation remains the most common surgical procedure in women, which demonstrated a 0.5 % increase over the past 4 years. As the number of women with breast implants increases, specialists and patients themselves face difficulties related to screening, diagnosis, and treatment of tumors, including breast cancer.Aim. To analyze specific characteristics of breast examination in patients after breast augmentation who were examined and treated in the mammological clinic of Russian Research Center of Radiology, Ministry of Health of the Russian Federation.Materials and methods. This study included 273 patients aged between 21 and 63 years (mean age 49.0 ± 7.6 years) after breast augmentation and after reconstructive surgery for breast cancer and symmetrizing surgery on the contralateral side. All women underwent clinical examination plus breast ultrasound (for patients under 40 years of age) or mammography followed by ultrasound (patients over 40 years of age). Patients who were found to have BI-RADS 3–4 tumors underwent ultrasound-guided or stereotactic breast biopsy. In case of suspicious intraductal formations according to breast nipple smears the patients were referred to breast ductography. Patients with suspected implant rupture or capsular contracture, as well as patients requiring the assessment of the disease stage underwent contrast-enhanced magnetic resonance imaging.Results. After comprehensive examination, 12 patients (5.4 %) were diagnosed with breast cancer; 38 patients (13.9 %), with implant rupture; 3 patients (1 %), with intraductal formations.Conclusion. Breast augmentation is not a contraindication to mammography in women aged over 40 years with glandular tissue. Additional examination methods include breast ultrasound, contrast-enhanced mammography, and breast magnetic resonance imaging. In case of no glandular tissue, contrast-enhanced breast magnetic resonance imaging and breast ultrasound are the methods of choice. It is important to develop new standards of screening and diagnosis of breast diseases in women after aesthetic surgery, since breast cancer incidence is likely to increase among women after breast augmentation over the next decades, considering the fact that breast cancer is the most common malignancy in women and its incidence is constantly growing.
- Open Access
- 7 August 2023
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 104 (2) , 151-162
Сontemporary Medical Decision Support Systems Based on Artificial Intelligence for the Analysis of Digital Mammographic Images
The relevance of implementing artificial intelligence (AI) technologies in the diagnosis of breast cancer (BC) is associated with a continuing high increase in BC incidence among women and its leading position in the structure of cancer incidence. Theoretically, using AI technologies is possible both at the stage of screening and in clarifying BC diagnosis. The article provides a brief overview of AI systems used in clinical practice and discusses their prospects in BC diagnosis. Advances in machine learning can be effective to improve the accuracy of mammography screening by reducing missed cancer cases and false positives.
- 7 August 2023
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 104 (2) , 151-162
Open AccessСontemporary Medical Decision Support Systems Based on Artificial Intelligence for the Analysis of Digital Mammographic Images
The relevance of implementing artificial intelligence (AI) technologies in the diagnosis of breast cancer (BC) is associated with a continuing high increase in BC incidence among women and its leading position in the structure of cancer incidence. Theoretically, using AI technologies is possible both at the stage of screening and in clarifying BC diagnosis. The article provides a brief overview of AI systems used in clinical practice and discusses their prospects in BC diagnosis. Advances in machine learning can be effective to improve the accuracy of mammography screening by reducing missed cancer cases and false positives.
- Open Access
- 5 August 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (2) , 94-103
Male breast cancer. Clinical experience of the Russian Scientific Center of Roentgenradiology of the Ministry of Health of Russia
Interest in male breast cancer is increasing every year due to the increase in the spread of this disease. However, the lack of randomized trials in male breast cancer draws the attention of specialists to this problem. Male breast cancer is 100 times less common than female. Over the past decades, there has been an increase in the disease up to 26 %. Low awareness of general practitioners, as well as the male part of the population, untimely access to specialized specialists are the reasons for the late diagnosis of the disease. Recommendations for the treatment of male breast cancer are based on the results of studies conducted in female with a similar diagnosis.In the period from January 2015 to September 2022, 13 patients diagnosed with male breast cancer were examined and treated in the Department of Oncology and Reconstructive Plastic Surgery of the Breast of the Russian Scientific Center of Roentgenradiology, Ministry of Health of Russia. The age of patients at the time of treatment ranged from 58 to 75 years, with a mean age of 63 years. In 2 patients (15 %), stage 0 was established, in 4 (31 %) – stage Ia, in 4 (31 %) – stage IIa, in 1 (7.6 %) – stage IIb, in 1 (7.7 %) – stage IIIb, in 1 (7.6 %) – stage IIIc. Two (15 %) patients underwent neoadjuvant polychemotherapy, 6 (46 %) patients underwent adjuvant polychemotherapy. In 7 (54 %) patients, surgical treatment was performed without further adjuvant polychemotherapy. Six (46 %) patients underwent radiation therapy. Hormone therapy was prescribed to all 13 (100 %) patients. When contacting the clinic, the most frequent complaints would be the appearance of a seal behind the nipple, discharge from the nipple.When diagnosing male breast cancer, the same methods are used as female. Tactics of treatment is determined individually. Early diagnosis of the disease and timely prescribed therapy lead to many years of remission.
- 5 August 2023
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (2) , 94-103
Open AccessMale breast cancer. Clinical experience of the Russian Scientific Center of Roentgenradiology of the Ministry of Health of Russia
Interest in male breast cancer is increasing every year due to the increase in the spread of this disease. However, the lack of randomized trials in male breast cancer draws the attention of specialists to this problem. Male breast cancer is 100 times less common than female. Over the past decades, there has been an increase in the disease up to 26 %. Low awareness of general practitioners, as well as the male part of the population, untimely access to specialized specialists are the reasons for the late diagnosis of the disease. Recommendations for the treatment of male breast cancer are based on the results of studies conducted in female with a similar diagnosis.In the period from January 2015 to September 2022, 13 patients diagnosed with male breast cancer were examined and treated in the Department of Oncology and Reconstructive Plastic Surgery of the Breast of the Russian Scientific Center of Roentgenradiology, Ministry of Health of Russia. The age of patients at the time of treatment ranged from 58 to 75 years, with a mean age of 63 years. In 2 patients (15 %), stage 0 was established, in 4 (31 %) – stage Ia, in 4 (31 %) – stage IIa, in 1 (7.6 %) – stage IIb, in 1 (7.7 %) – stage IIIb, in 1 (7.6 %) – stage IIIc. Two (15 %) patients underwent neoadjuvant polychemotherapy, 6 (46 %) patients underwent adjuvant polychemotherapy. In 7 (54 %) patients, surgical treatment was performed without further adjuvant polychemotherapy. Six (46 %) patients underwent radiation therapy. Hormone therapy was prescribed to all 13 (100 %) patients. When contacting the clinic, the most frequent complaints would be the appearance of a seal behind the nipple, discharge from the nipple.When diagnosing male breast cancer, the same methods are used as female. Tactics of treatment is determined individually. Early diagnosis of the disease and timely prescribed therapy lead to many years of remission.
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 1
Prepectoral implant-based breast reconstruction in patients with breast cancer
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить результаты реконструктивных операций при раке молочной железы путем препекторальной установки имплантатов. МАТЕРИАЛ И МЕТОДЫ В исследование включены 130 пациенток с диагнозом рака молочной железы, у которых на хирургическом этапе лечения выполнена реконструктивно-пластическая операция с одномоментной препекторальной установкой эндопротеза. РЕЗУЛЬТАТЫ Имплантаты с полиуретановым покрытием использованы в 69% случаев, текстурированные имплантаты — в 31% случаев. Чаще всего (в 87% случаев) данная реконструктивная операция выполнялась у пациентов с начальными стадиями заболевания (с 0—IIa стадиями). Химиотерапевтическое лечение после операции получили 62 (47,7%) пациентки. Лучевая терапия проведена в 35 (27%) случаях, из них 60% больных — с установленным полиуретановым имплантатом и 40% больных — с установленным текстурированным имплантатом. В ряде случаев имели место осложнения, которые в большинстве своем были получены на фоне проводимого лучевого и/или химиотерапевтического лечения. ЗАКЛЮЧЕНИЕ Одномоментная реконструкция молочной железы путем препекторального размещения имплантата является надежным и доступным методом реконструкции молочной железы. Очевидно влияние лучевой терапии и химиотерапии на вероятность некоторых видов осложнений. Совершенствование хирургических методик и методов профилактики осложнений позволит в дальнейшем более эффективно использовать препекторальную установку имплантатов для реконструкции молочной железы.
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 1
Prepectoral implant-based breast reconstruction in patients with breast cancer
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить результаты реконструктивных операций при раке молочной железы путем препекторальной установки имплантатов. МАТЕРИАЛ И МЕТОДЫ В исследование включены 130 пациенток с диагнозом рака молочной железы, у которых на хирургическом этапе лечения выполнена реконструктивно-пластическая операция с одномоментной препекторальной установкой эндопротеза. РЕЗУЛЬТАТЫ Имплантаты с полиуретановым покрытием использованы в 69% случаев, текстурированные имплантаты — в 31% случаев. Чаще всего (в 87% случаев) данная реконструктивная операция выполнялась у пациентов с начальными стадиями заболевания (с 0—IIa стадиями). Химиотерапевтическое лечение после операции получили 62 (47,7%) пациентки. Лучевая терапия проведена в 35 (27%) случаях, из них 60% больных — с установленным полиуретановым имплантатом и 40% больных — с установленным текстурированным имплантатом. В ряде случаев имели место осложнения, которые в большинстве своем были получены на фоне проводимого лучевого и/или химиотерапевтического лечения. ЗАКЛЮЧЕНИЕ Одномоментная реконструкция молочной железы путем препекторального размещения имплантата является надежным и доступным методом реконструкции молочной железы. Очевидно влияние лучевой терапии и химиотерапии на вероятность некоторых видов осложнений. Совершенствование хирургических методик и методов профилактики осложнений позволит в дальнейшем более эффективно использовать препекторальную установку имплантатов для реконструкции молочной железы.